BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10853236)

  • 1. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
    Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
    Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
    J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study.
    Wild T; Scherbaum WA; Gleichmann H; Landt M; Santiago J; Endl J; Landgraf R; Cavallo MG; Ganz M; Pozzilli P
    Horm Metab Res; 1997 Aug; 29(8):403-6. PubMed ID: 9288579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
    Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65.
    Akamine H; Komiya I; Shimabukuro T; Asawa T; Tanaka H; Yagi N; Taira T; Nagata K; Arakaki K; Wakugami T; Takasu N; Powell MJ; Furmaniak J; Smith BR
    Diabet Med; 1997 Sep; 14(9):778-84. PubMed ID: 9300229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY; Huang P; Lou HL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
    Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
    Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
    Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
    Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
    Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
    Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
    Prázný M; Skrha J; Límanová Z; Hilgertová J
    Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.